Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With ...

A report by MedCity ranks London as the number one city in Europe and the third city globally for life sciences. The Global ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our ...

Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended Adcetris ...

In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands ...

We found that most respondents had a positive perception of gene therapy, with 37% rating their perception as ‘very positive’ ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

While AI tools offer undeniable benefits, they also risk diminishing our engagement in deep, reflective thinking and learning ...

Sanofi’s Qfitlia (fitusiran) has been approved by the US Food and Drug Administration (FDA) as the first therapy to treat ...

Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...